Service
Drug Discovery
Nexus BioQuest offers preclinical Drug Discovery and non-regulatory clinical Biomarker services that support the development of immune therapies.
We use relevant cell lines, primary human cells and patient material in our assays to evaluate target engagement, lead candidate identification and optimisation. Built into the work flow are predictive immuno toxicity and Biomarker assays resulting in a comprehensive drug candidate data package
